Animal Testing
The End of an Era: What the FDA's Move Away from Animal Testing Means for Biopharma
Daniel Smith, Ph.D.
Nice Consulting
PAO-04-25-NI-06Apr 14, 2025
In Vitro Biology
Piramal Pharma Solutions Launches In-Vitro Biology Capabilities at Ahmedabad Discovery Services Site
Piramal Pharma Solutions
PR-M10-23-04Oct 17, 2023
Biocompatibility
Championing In Vitro Biocompatibility/Biological Reactivity Testing for Plastics Used in Pharma Manufacturing
Janmeet Anant; Monica Cardona
MilliporeSigma
PAO-06-21-CL-09Jun 21, 2021
Tissue Models
Accurately Recapitulating Environmental Niches in In Vitro Models of the Intestine
Liz Boazak, Ph.D.
Altis Biosystems
PAO-03-21-CL-01Mar 11, 2021
Tissue Models
Developing a Robust In Vitro Intestinal Model for Preclinical Candidate Screening of GI Toxicity
Ron Laethem, Ph.D.
Altis Biosystems
PAO-02-21-CL-04Feb 18, 2021
Tissue Models
Recapitulating the Multifaceted Inflammatory Environment of the Intestine In Vitro
Bailey Zwarycz, Ph.D
Altis Biosystems
PAO-02-21-CL-01Feb 04, 2021
Tissue Models
The Power of RepliGut In Vitro Intestinal Stem Cell Models
Bailey Zwarycz, Ph.D
Altis Biosystems
PA1081Jan 26, 2021
Drug Discovery
Heart-on-a-Chip Mimics Drug Response Seen in Humans: In Vitro Approach Provides Predictive Platform for Human-Based Drug Discovery
TARA Biosystems
PR-M08-19-NI-045Aug 16, 2019
Market Prediction
In Vitro ADME Testing Services Market, 2019-2030
ReportLinker
PR-M03-19-NI-055Mar 20, 2019
Drug Development
Fucoidans Found in Seaweed Exhibit Promising Anticancer Properties
Emilie Branch
Pharma's Almanac
PAO-M12-17-NI-025Dec 15, 2017
Innovation
Modeling Patient-Specific Kidney Diseases by Combining Engineered Stem Cells and Chip Technology
Emilie Branch
Pharma's Almanac
PAO-M05-17-NI-018May 19, 2017